BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 3499498)

  • 1. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
    Strauchen JA; Dimitriu-Bona A
    Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
    Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BLA.36: a glycoprotein specifically expressed on the surface of Hodgkin's and B cells.
    Imam A; Stathopoulos E; Taylor CR
    Anticancer Res; 1990; 10(4):1095-104. PubMed ID: 1696446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
    Pinkus GS; Said JW
    Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of a monoclonal antibody that binds Reed-Sternberg cells.
    Hecht TT; Longo DL; Cossman J; Bolen JB; Hsu SM; Israel M; Fisher RI
    J Immunol; 1985 Jun; 134(6):4231-6. PubMed ID: 3157756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease.
    Hsu SM; Yang K; Jaffe ES
    Am J Pathol; 1985 Feb; 118(2):209-17. PubMed ID: 3970138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
    Frierson HF; Innes DJ
    Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.
    Poppema S
    Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by Hodgkin's disease cells.
    Fisher RI; Cossman J; Diehl V; Volkman DJ
    J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reaction of xenogeneic and monoclonal antisera with Reed-Sternberg cells.
    Stuart AE; Jackson E; Morris CS
    J Pathol; 1982 Jun; 137(2):129-38. PubMed ID: 6979620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
    Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
    Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.